Early evaluation of the biological activity of the natural mandelalides had revealed a sensitivity of at least two LKB1-null human cancer cells (HeLa cervical and NCI-H460 NSCLCs [1,9]), leading us to investigate LKB1 status as a potential determinant of mandelalide sensitivity. Here, STK11 is linked to cancer.